Use of Real-World Evidence in HTA

Expert Workshop

November 6th, 2024 – 3:00-4:00pm GMT

Moderated by Prof. Keith Abrams

Professor of Statistics & Data Science, University of Warwick

Partner and Director of Statistics, Visible Analytics

Visible Analytics are hosting a live webinar this November.

Join us for an engaging webinar to explore the transformative power of RWE in HTA and how it’s driving better healthcare decisions and patient outcomes.

Our expert speakers--Dr. James Rafferty, Prof. Neil Hawkins, Dr. Jonathan Broomfield, and Dr. Edit Remak--will dive into key topics, including:

  • Target trial emulation and informative observations
  • Use of RWE in an assessment of Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome
  • Using RWE to estimate life-expectancy in natural history models
  • RWE to guide model conceptualisation in an ultra-rare disease

Introduction and Q&A session will be led by Prof. Keith R Abrams, widely recognised authority in the fields of RWE and HTA. 

Whether you're involved in clinical research, HEOR, or strategic HTA decisions, join the discussion on how RWE can make a real impact on decision-making in healthcare.

Register now and secure your spot. We look forward to seeing you there!

If you require additional information or wish to submit a question to our panellists ahead of live discussion, please email us at enquiries@visibleanalytics.co.uk. Presenter slides will be made available following the webinar, so get in touch to request a copy. 

Dr. James Rafferty
Swansea Univesity

Neil Hawkins

Prof. Neil Hawkins
University of Glasgow
Visible Analytics

Dr. Jonathan Broomfield
University of Leicester

Dr. Edit Remak
Visible Analytics